tiprankstipranks
Advertisement
Advertisement

MPLT Stock Latest News

Midday Fly By: Nvidia reports Q1 beat, SpaceX files for IPO
The FlyMidday Fly By: Nvidia reports Q1 beat, SpaceX files for IPO
2d ago
DE
KD
Craig-Hallum bullish on MapLight Therapeutics, initiates with a Buy
PremiumThe Fly
Craig-Hallum bullish on MapLight Therapeutics, initiates with a Buy
2d ago
MPLT
MapLight Therapeutics initiated with a Buy at Craig-Hallum
PremiumThe Fly
MapLight Therapeutics initiated with a Buy at Craig-Hallum
2d ago
MPLT
Analyst Reiterates Buy on MapLight, Maintains $37 Price Target on Confidence in ML-007 and Pipeline Upside
PremiumRatings
Analyst Reiterates Buy on MapLight, Maintains $37 Price Target on Confidence in ML-007 and Pipeline Upside
3d ago
MPLT
Buy Rating Reiterated on Clinical Catalysts and Strong Cash Runway; $37 Price Target Unchanged
PremiumRatings
Buy Rating Reiterated on Clinical Catalysts and Strong Cash Runway; $37 Price Target Unchanged
8d ago
MPLT
MapLight Therapeutics Expands Pipeline Amid Rising Quarterly Losses
PremiumCompany AnnouncementsMapLight Therapeutics Expands Pipeline Amid Rising Quarterly Losses
9d ago
8K
MPLT
MapLight Therapeutics reports Q1 EPS ($1.34), consensus ($1.12)
Premium
The Fly
MapLight Therapeutics reports Q1 EPS ($1.34), consensus ($1.12)
9d ago
MPLT
MapLight Therapeutics initiated with an Outperform at LifeSci Capital
Premium
The Fly
MapLight Therapeutics initiated with an Outperform at LifeSci Capital
9d ago
MPLT
MapLight Therapeutics management to meet with Needham
PremiumThe Fly
MapLight Therapeutics management to meet with Needham
11d ago
MPLT
MapLight Therapeutics initiated with a Buy at H.C. Wainwright
PremiumThe Fly
MapLight Therapeutics initiated with a Buy at H.C. Wainwright
19d ago
MPLT
MapLight Therapeutics completes enrollment in ZEPHYR trial
PremiumThe Fly
MapLight Therapeutics completes enrollment in ZEPHYR trial
22d ago
MPLT
MapLight Therapeutics Announces Board Refresh and New Nominees
PremiumCompany Announcements
MapLight Therapeutics Announces Board Refresh and New Nominees
24d ago
8K
MPLT
MapLight Therapeutics initiated with a Buy at Needham
PremiumThe FlyMapLight Therapeutics initiated with a Buy at Needham
2M ago
MPLT
Buy Rating on MapLight: Differentiated CNS Pipeline and Undervalued Schizophrenia Opportunity with Upside in Alzheimer’s and Neuropsychiatric Indications
Premium
Ratings
Buy Rating on MapLight: Differentiated CNS Pipeline and Undervalued Schizophrenia Opportunity with Upside in Alzheimer’s and Neuropsychiatric Indications
2M ago
MPLT
MapLight Therapeutics initiated with a Buy at TD Cowen
Premium
The Fly
MapLight Therapeutics initiated with a Buy at TD Cowen
2M ago
MPLT
MapLight Therapeutics Highlights Growing CNS Pipeline, Strong Cash Position
PremiumCompany Announcements
MapLight Therapeutics Highlights Growing CNS Pipeline, Strong Cash Position
2M ago
8K
MPLT
Canaccord starts MapLight with Buy into schizophrenia data
PremiumThe Fly
Canaccord starts MapLight with Buy into schizophrenia data
2M ago
MPLT
MapLight Therapeutics initiated with a Buy at Canaccord
PremiumThe Fly
MapLight Therapeutics initiated with a Buy at Canaccord
2M ago
MPLT
MapLight updates trial timelines and highlights CNS pipeline
PremiumCompany Announcements
MapLight updates trial timelines and highlights CNS pipeline
4M ago
8K
MPLT
MapLight Therapeutics expects topline results from ZEPHYR trial in Q3
PremiumThe FlyMapLight Therapeutics expects topline results from ZEPHYR trial in Q3
4M ago
MPLT
MapLight Therapeutics receives fast track designation for ML-007C-MA for ADP
Premium
The Fly
MapLight Therapeutics receives fast track designation for ML-007C-MA for ADP
5M ago
MPLT
MapLight’s Phase 2 Alzheimer’s Psychosis Trial Marks a Key Milestone for MPLT Investors
Premium
Company Announcements
MapLight’s Phase 2 Alzheimer’s Psychosis Trial Marks a Key Milestone for MPLT Investors
5M ago
MPLT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >